| 1 |
33302041 | p38 Mitogen-activated protein kinase modulates cisplatin resistance in Head and Neck Squamous Cell Carcinoma cells. | 2021 Feb |
8 |
| 2 |
33990641 | trans-Fatty acids promote p53-dependent apoptosis triggered by cisplatin-induced DNA interstrand crosslinks via the Nox-RIP1-ASK1-MAPK pathway. | 2021 May 14 |
1 |
| 3 |
34008860 | Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK/p-38 and suppression of MMP-2/9. | 2021 Jun |
1 |
| 4 |
34216662 | A novel platform for drug testing: Biomimetic three-dimensional hyaluronic acid-based scaffold seeded with human hepatocarcinoma cells. | 2021 Aug 31 |
1 |
| 5 |
34533242 | Rosamultin from Potentilla anserine L. exhibits nephroprotection and antioxidant activity by regulating the reactive oxygen species/C/EBP homologous protein signaling pathway. | 2021 Nov |
1 |
| 6 |
34790784 | TRPA1 promotes cisplatin-induced nephrotoxicity through inflammation mediated by the MAPK/NF-κB signaling pathway. | 2021 Oct |
1 |
| 7 |
31991751 | Asiatic Acid, Extracted from Centella asiatica and Induces Apoptosis Pathway through the Phosphorylation p38 Mitogen-Activated Protein Kinase in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells. | 2020 Jan 25 |
2 |
| 8 |
32252293 | Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells. | 2020 Apr 2 |
1 |
| 9 |
32533982 | Enhanced expression of lncRNA ZXF1 promotes cisplatin resistance in lung cancer cell via MAPK axis. | 2020 Oct |
1 |
| 10 |
32764530 | Reelin Promotes Cisplatin Resistance by Induction of Epithelial-Mesenchymal Transition via p38/GSK3β/Snail Signaling in Non-Small Cell Lung Cancer. | 2020 Aug 7 |
2 |
| 11 |
30944654 | TNFAIP8 promotes cisplatin resistance in cervical carcinoma cells by inhibiting cellular apoptosis. | 2019 May |
1 |
| 12 |
31205536 | CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling. | 2019 |
2 |
| 13 |
31706153 | System-level responses to cisplatin in pro-apoptotic stages of breast cancer MCF-7 cell line. | 2019 Dec |
1 |
| 14 |
31929796 | Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based Chemotherapy. | 2019 |
1 |
| 15 |
31983124 | Cetuximab combined with cisplatin improves the prognosis of gastric cancer patients and its effect on P38 MAPK expression. | 2019 Nov-Dec |
2 |
| 16 |
29518977 | Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach. | 2018 Mar 7 |
3 |
| 17 |
29575240 | Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma. | 2018 May |
2 |
| 18 |
29805654 | Cisplatin-induced non-canonical endocytosis of EGFR via p38 phosphorylation of the C-terminal region containing Ser-1015 in non-small cell lung cancer cells. | 2018 Jun |
2 |
| 19 |
29983416 | p38 MAPK pathway and its interaction with TRF2 in cisplatin induced chemotherapeutic response in head and neck cancer. | 2018 Jul 9 |
2 |
| 20 |
30032449 | Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation. | 2018 Oct |
1 |
| 21 |
30267330 | Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway. | 2018 Dec |
3 |
| 22 |
30344920 | The antiangiogenic action of cisplatin on endothelial cells is mediated through the release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. | 2018 Sep 25 |
1 |
| 23 |
28120035 | The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy. | 2017 Feb |
1 |
| 24 |
28927101 | Effects of p38MAPK-mediated excision repair cross-complementation 1 expression on prognosis of patients with non-small cell lung cancer. | 2017 Sep |
1 |
| 25 |
26872057 | The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer. | 2016 Mar 22 |
2 |
| 26 |
27026405 | Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells. | 2016 Jun |
5 |
| 27 |
27184254 | HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells. | 2016 May 17 |
1 |
| 28 |
27313779 | P53 Is Involved in a Three-Dimensional Architecture-Mediated Decrease in Chemosensitivity in Colon Cancer. | 2016 |
1 |
| 29 |
27537399 | Id4 promotes cisplatin resistance in lung cancer through the p38 MAPK pathway. | 2016 Nov |
4 |
| 30 |
27825085 | AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1. IMPLICATION OF AKT2 IN CHEMORESISTANCE. | 2016 Oct 21 |
1 |
| 31 |
25701783 | Role of tyrosine kinase-independent phosphorylation of EGFR with activating mutation in cisplatin-treated lung cancer cells. | 2015 Mar 20 |
1 |
| 32 |
25765877 | Platinum-induced neurotoxicity and preventive strategies: past, present, and future. | 2015 Apr |
1 |
| 33 |
25894720 | Cisplatin resistance in human cervical, ovarian and lung cancer cells. | 2015 Jun |
2 |
| 34 |
26018318 | Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15. | 2015 Sep |
2 |
| 35 |
26066081 | WASH and Tsg101/ALIX-dependent diversion of stress-internalized EGFR from the canonical endocytic pathway. | 2015 Jun 12 |
1 |
| 36 |
26118633 | Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways. | 2015 Sep |
1 |
| 37 |
26171149 | p38 mitogen-activated protein kinase inhibits USP22 transcription in HeLa cells. | 2015 Jul |
1 |
| 38 |
26310353 | Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a. | 2015 Oct |
5 |
| 39 |
26568478 | Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers. | 2015 Nov 16 |
3 |
| 40 |
26586936 | Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth. | 2015 |
3 |
| 41 |
23297007 | Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death. | 2014 Feb |
1 |
| 42 |
24215867 | Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A. | 2014 Mar 1 |
1 |
| 43 |
24690178 | Sensitization of mesothelioma cells to platinum-based chemotherapy by GSTπ knockdown. | 2014 Apr 25 |
1 |
| 44 |
24796665 | Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines. | 2014 Jun 27 |
1 |
| 45 |
24851838 | Neuroprotection elicited by P2Y13 receptors against genotoxic stress by inducing DUSP2 expression and MAPK signaling recovery. | 2014 Sep |
2 |
| 46 |
24988892 | Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation. | 2014 Sep |
1 |
| 47 |
25006835 | Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin. | 2014 Jul 8 |
1 |
| 48 |
25110412 | p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. | 2014 Aug 7 |
1 |
| 49 |
25118792 | Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer. | 2014 Nov |
7 |
| 50 |
25152024 | Mig-2 attenuates cisplatin-induced apoptosis of human glioma cells in vitro through AKT/JNK and AKT/p38 signaling pathways. | 2014 Sep |
2 |